| Application number | Title of the application | Filing Date | Status |
|---|
| 08/296133 | DIRECTED HUMAN IMMUNE GLOBULIN FOR THE PREVENTION AND TREATMENT OF STAPHYLOCOCCAL INFECTIONS | Aug 25, 1994 | Abandoned |
Array
(
[id] => 3703070
[patent_doc_number] => 05646255
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C'
[patent_app_type] => 1
[patent_app_number] => 8/290342
[patent_app_country] => US
[patent_app_date] => 1994-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8638
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/646/05646255.pdf
[firstpage_image] =>[orig_patent_app_number] => 290342
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/290342 | Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C | Aug 14, 1994 | Issued |
Array
(
[id] => 3754593
[patent_doc_number] => 05851523
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/290381
[patent_app_country] => US
[patent_app_date] => 1994-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 7435
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/851/05851523.pdf
[firstpage_image] =>[orig_patent_app_number] => 290381
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/290381 | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | Aug 14, 1994 | Issued |
| 08/278634 | HLA BINDING PEPTIDES AND THEIR USES | Jul 20, 1994 | Abandoned |
| 08/272220 | INVARIANT CHAIN COMPOSITIONS USEFUL FOR TREATING AUTOIMMUNE DISEASES | Jul 7, 1994 | Abandoned |
Array
(
[id] => 3691707
[patent_doc_number] => 05618542
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Vaccines comprising antigenic polypeptides of Taenia ovis'
[patent_app_type] => 1
[patent_app_number] => 8/268535
[patent_app_country] => US
[patent_app_date] => 1994-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8852
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618542.pdf
[firstpage_image] =>[orig_patent_app_number] => 268535
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/268535 | Vaccines comprising antigenic polypeptides of Taenia ovis | Jul 5, 1994 | Issued |
Array
(
[id] => 3589047
[patent_doc_number] => 05552529
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Autoantigen, pinch'
[patent_app_type] => 1
[patent_app_number] => 8/269441
[patent_app_country] => US
[patent_app_date] => 1994-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13464
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552529.pdf
[firstpage_image] =>[orig_patent_app_number] => 269441
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/269441 | Autoantigen, pinch | Jun 29, 1994 | Issued |
| 08/266802 | POLYPEPTIDE DERIVED FROM THE MALARIA PARASITE | Jun 26, 1994 | Abandoned |
Array
(
[id] => 3654516
[patent_doc_number] => 05591430
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/261160
[patent_app_country] => US
[patent_app_date] => 1994-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 6548
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591430.pdf
[firstpage_image] =>[orig_patent_app_number] => 261160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261160 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Jun 16, 1994 | Issued |
Array
(
[id] => 3937342
[patent_doc_number] => 05976531
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Composite antibodies of human subgroup IV light chain capable of binding to tag-72'
[patent_app_type] => 1
[patent_app_number] => 8/261354
[patent_app_country] => US
[patent_app_date] => 1994-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 31
[patent_no_of_words] => 19798
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976531.pdf
[firstpage_image] =>[orig_patent_app_number] => 261354
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261354 | Composite antibodies of human subgroup IV light chain capable of binding to tag-72 | Jun 15, 1994 | Issued |
| 08/260548 | IMMUNE MODULATION WITH CLASS II ALPHA-CHAIN FRAGMENTS | Jun 15, 1994 | Abandoned |
| 08/259145 | METHODS OF TREATING ANGIOGENESIS-INDUCED DISEASES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Jun 12, 1994 | Abandoned |
| 08/253782 | MODIFIED CELLS AND METHODS FOR INHIBITING HYPERACUTE REJECTION OF XENOGENEIC TRANSPLANTS | Jun 2, 1994 | Abandoned |
| 08/249996 | PREVENTION AND IMPROVEMENT OF MEDICAL SYSTEMS CAUSED BY LEUCOTRIENE B4 | May 26, 1994 | Abandoned |
Array
(
[id] => 3659493
[patent_doc_number] => 05648240
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'MHC II analog from Staphylococcus aureus'
[patent_app_type] => 1
[patent_app_number] => 8/248021
[patent_app_country] => US
[patent_app_date] => 1994-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 4889
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648240.pdf
[firstpage_image] =>[orig_patent_app_number] => 248021
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/248021 | MHC II analog from Staphylococcus aureus | May 23, 1994 | Issued |
| 08/247572 | ANTIBODY RECOGNIZING ENDOTHELIAL CELL LIGAND FOR LEUKOCYTE CR3 | May 22, 1994 | Abandoned |
Array
(
[id] => 3820747
[patent_doc_number] => 05730983
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma'
[patent_app_type] => 1
[patent_app_number] => 8/224000
[patent_app_country] => US
[patent_app_date] => 1994-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 14485
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/730/05730983.pdf
[firstpage_image] =>[orig_patent_app_number] => 224000
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/224000 | Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma | May 18, 1994 | Issued |
| 08/245337 | CHIMERIC MHC CLASS I ANTIGENS FOR INDUCING ALLOGRAFT TOLERANCE | May 17, 1994 | Abandoned |
Array
(
[id] => 3904064
[patent_doc_number] => 05897861
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Bispecific reagents for AIDS therapy'
[patent_app_type] => 1
[patent_app_number] => 8/243070
[patent_app_country] => US
[patent_app_date] => 1994-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5699
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/897/05897861.pdf
[firstpage_image] =>[orig_patent_app_number] => 243070
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/243070 | Bispecific reagents for AIDS therapy | May 15, 1994 | Issued |
Array
(
[id] => 3683091
[patent_doc_number] => 05690941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes'
[patent_app_type] => 1
[patent_app_number] => 8/242060
[patent_app_country] => US
[patent_app_date] => 1994-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10105
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/690/05690941.pdf
[firstpage_image] =>[orig_patent_app_number] => 242060
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/242060 | Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes | May 12, 1994 | Issued |
